levofloxacin has been researched along with butenafine in 1 studies
Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (butenafine) | Trials (butenafine) | Recent Studies (post-2010) (butenafine) |
---|---|---|---|---|---|
4,346 | 581 | 2,209 | 72 | 12 | 29 |
Protein | Taxonomy | levofloxacin (IC50) | butenafine (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 3.9099 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.6443 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.3 | |
Acetylcholinesterase | Homo sapiens (human) | 6.9071 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 3.9099 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.4118 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 3.9533 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
1 other study(ies) available for levofloxacin and butenafine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |